GENE ONLINE|News &
Opinion
Blog

Venture Capital
How Can Taiwan’s Biopharma Seize the Next Global Business Opportunity? – An Interview with Dr. Jerome Shen
2021-10-17
What are Investors Looking for in a Biotech Startup?
2021-07-27
Finding Strategic Partnerships: Insider Perspectives On Biopharma Deals and Market Trends
2021-06-18
Scribe Therapeutics Bags $100 Million in Series B to Advance CRISPR-Based Therapies
2021-04-01
BIOCEO21 Highlights: Criteria for Successful Launches of Biotech SPACs
2021-02-21
BIOCEO21: Scientists and Investors Weigh on Pioneering Innovations and Investments in Oncology
2021-02-18
Sana Biotechnology Makes Wall Street Debut with $587.5 Million IPO
2021-02-05
Putting the Bio in Canadian Biomanufacturing
2020-12-25
Top Highlights of BIO Asia-Taiwan 2020
2020-07-29Partner
A New Paradigm in Biotech Innovation and Investment
2020-07-24Partner
BIO Asia–Taiwan 2020 Online + Live for the Opportunity to Share Your Company’s Achievements and Goals
2020-05-30Partner
Company Presentations at BIO Asia-Taiwan 2020 Now Accepting Applications
2020-02-26
LATEST
Novel RAGE Antagonist Stirs Hopes for Countering Diabetic Complications
2021-12-07
AstraZeneca Blocks Private Equity Buyout of Swedish Pharma Sobi
2021-12-06
Coherent Biopharma, WuXi STA Collab Takes a Crack at Peptide-Drug Conjugates
2021-12-06
How CDMOs are Restructuring the Biopharma Landscape – An Interview with Bobby Sheng
2021-12-06
BeiGene launches IPO on Shanghai’s STAR market to raise $3B
2021-12-03
Novartis, UCB Take Aim at Parkinson’s Disease Under $1.65 Billion Collab
2021-12-03
Atara Biotherapeutics’ First-In-Class Allogeneic T-Cell Therapy Accepted for EMA Review
2021-12-02
EVENT
2021-12-13
63rd ASH ANNUAL MEETING AND EXPOSITION
Georgia, USA
2021-12-28
BIOHK2021
Hong Kong, China
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!